Massachusetts Financial Services Co. MA Sells 100,825 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Massachusetts Financial Services Co. MA decreased its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 4.0% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,418,098 shares of the company’s stock after selling 100,825 shares during the period. Massachusetts Financial Services Co. MA owned about 1.42% of Option Care Health worth $56,100,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the business. Vanguard Group Inc. raised its stake in Option Care Health by 0.4% in the 4th quarter. Vanguard Group Inc. now owns 19,315,421 shares of the company’s stock valued at $448,118,000 after acquiring an additional 75,313 shares during the period. Wellington Management Group LLP increased its holdings in shares of Option Care Health by 84.6% in the fourth quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company’s stock valued at $425,143,000 after purchasing an additional 8,400,208 shares during the last quarter. State Street Corp raised its position in shares of Option Care Health by 1.4% in the third quarter. State Street Corp now owns 6,257,172 shares of the company’s stock valued at $195,849,000 after purchasing an additional 83,395 shares during the period. Norges Bank acquired a new stake in shares of Option Care Health during the 4th quarter worth about $60,219,000. Finally, Charles Schwab Investment Management Inc. boosted its holdings in shares of Option Care Health by 6.2% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company’s stock worth $58,235,000 after buying an additional 147,054 shares during the period. 98.05% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts have weighed in on OPCH shares. Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and increased their price target for the company from $26.00 to $33.00 in a report on Monday, January 13th. JPMorgan Chase & Co. lifted their price target on Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a report on Thursday, March 6th. Barrington Research upped their price objective on Option Care Health from $33.00 to $38.00 and gave the company an “outperform” rating in a report on Thursday, February 27th. JMP Securities reissued a “market outperform” rating and set a $30.00 target price (down previously from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Finally, Jefferies Financial Group upgraded shares of Option Care Health from a “hold” rating to a “buy” rating and upped their price target for the company from $26.00 to $35.00 in a research note on Thursday, January 23rd. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $33.00.

Option Care Health Stock Down 4.0 %

Shares of NASDAQ OPCH opened at $33.54 on Friday. The stock has a market capitalization of $5.51 billion, a P/E ratio of 28.18, a PEG ratio of 2.30 and a beta of 1.07. The stock’s fifty day moving average is $32.97 and its 200 day moving average is $28.51. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73.

Insiders Place Their Bets

In other news, insider Michael Bavaro sold 30,996 shares of the company’s stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the sale, the insider now owns 44,974 shares of the company’s stock, valued at approximately $1,495,835.24. This represents a 40.80 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.64% of the company’s stock.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.